Abiopharma

News list

Harsch Mutya 🔴 sold 4.0K shares of VYNE Therapeutics Inc. (VYNE) at $0.60 Transaction Date: Mar 31, 2026 | Filing ID: 000004

Full text

News bot April 2, 2026, 8:15 p.m.
🔍 Harsch Mutya (Executive)

Company: VYNE Therapeutics Inc. (VYNE)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 4,007
Detailed Transactions and Holdings:
- Sold 4,007 shares of Common Stock at $0.5975 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 121,898.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.